407 research outputs found

    Exact Essential-Hazard-Free State Minimization of Incompletely Specified Asynchronous Sequential Machines

    Get PDF
    To insure correct dynamic behaviour of asynchronous sequential machines, hazards must be eliminated for they may cause malfunctions of the whole system. However, Hazard-free state minimization has received almost no prior attention in the literature. This paper describes an exact algorithm for essential-hazard-free state minimization of incompletely specified asynchronous sequential machines. Novel techniques for the elimination of apparent and potential essential hazards are proposed and exploited in our algorithm. The algorithm has been implemented and applied to over a dozen asynchronous sequential machines. Results are compared with results of non-essential-hazard-free method SIS. Most of the tested cases can be reduced to essential hazard free flow tables

    Performance Comparison of Time-Step-Driven versus Event-Driven Neural State Update Approaches in SpiNNaker

    Get PDF
    The SpiNNaker chip is a multi-core processor optimized for neuromorphic applications. Many SpiNNaker chips are assembled to make a highly parallel million core platform. This system can be used for simulation of a large number of neurons in real-time. SpiNNaker is using a general purpose ARM processor that gives a high amount of flexibility to implement different methods for processing spikes. Various libraries and packages are provided to translate a high-level description of Spiking Neural Networks (SNN) to low-level machine language that can be used in the ARM processors. In this paper, we introduce and compare three different methods to implement this intermediate layer of abstraction. We have examined the advantages of each method by various criteria, which can be useful for professional users to choose between them. All the codes that are used in this paper are available for academic propose.EU H2020 grant 644096 ECOMODEEU H2020 grant 687299 NEURAM3Ministry of Economy and Competitivity (Spain) / European Regional Development Fund TEC2015-63884-C2-1-P (COGNET

    The Extended Synthesis: Something Old, Something New

    Get PDF
    Abstract The eclipse of Darwinism began to end in the 1980s and hangs in the balance today. We need an Extended Synthesis, using “extension” metaphorically. We must extend back in time to recover important aspects of Darwinism that were set aside, and then lost during neo-Darwinism, then move forward beyond neo-Darwinism to encompass new data and concepts. The most comprehensive framework for the Extended Synthesis is the Major Transitions in Evolution. The Extended Synthesis rests comfortably within a philosophical perspective in which biology does not need to be connected with other areas of science in order to justify itself. I am attracted to an older concept in which biology needs a covering law to connect it with the rest of the natural sciences. Darwin implicated a “higher law,” but did not specify it. If we can elucidate that law, the Extended Synthesis will become the Unified Theory of Biology called for by Brooks and Wiley 25 years ago

    Avances en la inmunosupresión para el trasplante renal. Nuevas estrategias para preservar la función renal y reducir el riesgo cardiovascular

    Get PDF
    The development of new immunosuppressants for renal transplantation is aimed not only at improving short-term outcomes, but also at achieving better safety, cardiovascular, and metabolic profiles and at decreasing nephrotoxicity. Belatacept is a fusion protein that inhibits T cell activation by binding to CD80 and CD86 antigens. Clinical trials, particularly the BENEFIT and BENEFIT-EXT studies, have shown that belatacept preserves function and structure in renal grafts. The effects of belatacept provide long-term, sustained results, and the safety and efficacy of this drug have been demonstrated in cases of renal transplantation from expanded criteria donors. Compared to calcineurin inhibitors, belatacept is associated with a lower incidence of chronic allograft nephropathy and a more favourable cardiovascular and metabolic profile
    corecore